Yu Xue Song - Net Worth and Insider Trading

Yu Xue Song Net Worth

The estimated net worth of Yu Xue Song is at least $469,686 dollars as of 2024-06-25. Yu Xue Song is the Directors, executives of Fuan Pharmaceutical (Group) Co Ltd and owns about 126,600 shares of Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) stock worth over $469,686. Details can be seen in Yu Xue Song's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yu Xue Song has not made any transactions after 2019-12-31 and currently still holds the listed stock(s).

Transaction Summary of Yu Xue Song

Yu Xue Song Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yu Xue Song owns 1 companies in total, including Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) .

Click here to see the complete history of Yu Xue Song’s form 4 insider trades.

Insider Ownership Summary of Yu Xue Song

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300194	Fuan Pharmaceutical (Group) Co Ltd	2019-12-31	Directors & executives

Yu Xue Song Latest Holdings Summary

Yu Xue Song currently owns a total of 1 stock. Yu Xue Song owns 126,600 shares of Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) as of December 31, 2019, with a value of $469,686.

Latest Holdings of Yu Xue Song

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300194	Fuan Pharmaceutical (Group) Co Ltd	2019-12-31	126,600	3.71	469,686

Holding Weightings of Yu Xue Song

Yu Xue Song Form 4 Trading Tracker

According to the SEC Form 4 filings, Yu Xue Song has made a total of 1 transactions in Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fuan Pharmaceutical (Group) Co Ltd is the sale of 42,200 shares on December 31, 2019, which brought Yu Xue Song around $232,944.

Insider Trading History of Yu Xue Song

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yu Xue Song Trading Performance

GuruFocus tracks the stock performance after each of Yu Xue Song's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yu Xue Song is 7.3%. GuruFocus also compares Yu Xue Song's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yu Xue Song within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yu Xue Song's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yu Xue Song

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-4.41
Relative Return to S&P 500(%)	0.58

Yu Xue Song Ownership Network

Ownership Network List of Yu Xue Song

No Data

Ownership Network Relation of Yu Xue Song

Yu Xue Song Owned Company Details

What does Fuan Pharmaceutical (Group) Co Ltd do?

Who are the key executives at Fuan Pharmaceutical (Group) Co Ltd?

Yu Xue Song is the Directors & executives of Fuan Pharmaceutical (Group) Co Ltd. Other key executives at Fuan Pharmaceutical (Group) Co Ltd include Executives Wu Xiong Hui , Directors & executives Huang Tao , and Executives Feng Jing .

Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fuan Pharmaceutical (Group) Co Ltd Insider Transactions

No Available Data

Yu Xue Song Mailing Address

Above is the net worth, insider trading, and ownership report for Yu Xue Song. Currently GuruFocus does not have mailing address information for Yu Xue Song.

Discussions on Yu Xue Song

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.